Institution: | 1.Research and Development Centre, GlaxoSmithKline (GSK), Siena, Italy ;2.Monoclonal Antibody Discovery (MAD) Lab, Fondazione Toscana Life Sciences, Siena, Italy ;3.University of Siena, Department of Biotechnology, Chemistry and Pharmacy, Siena, Italy |